From COVID-19 vaccines to Moderna’s mRNA flu vaccine, using mRNA as medicine has shown promise. But before mRNA drugs can go ...

Investors seeking reliable income have no shortage of options today. For the most risk-averse, short-term bonds are currently ...

AI’s greatest mathematical successes have come from answers to problems posed by a mid-20th century iconoclast. By examining ...

OpenAI has revealed Astra, an unreleased model designed to tackle complex, long-running tasks, after an internal version ...

MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2026 ended July 3, 2026.